Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:1794-1801
Published online before print September 4, 2009, doi: 10.1161/ATVBAHA.109.194019
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
29/11/1794    most recent
ATVBAHA.109.194019v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Nickerson, M. M.
Right arrow Articles by Price, R. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nickerson, M. M.
Right arrow Articles by Price, R. J.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:1794.)
© 2009 American Heart Association, Inc.


Integrative Physiology/Experimental Medicine

Bone Marrow–Derived Cell-Specific Chemokine (C-C Motif) Receptor-2 Expression is Required for Arteriolar Remodeling

Meghan M. Nickerson; Ji Song; Joshua K. Meisner; Sameer Bajikar; Caitlin W. Burke; Casey W. Shuptrine; Gary K. Owens; Thomas C. Skalak; Richard J. Price

From the Department of Biomedical Engineering (M.M.N., J.S., J.K.M., S.B., C.W.B., C.W.S., T.C.S., R.J.P.), the Department of Molecular Physiology and Biological Physics (G.K.O.), and the Robert M. Berne Cardiovascular Research Center (G.K.O., R.J.P.), University of Virginia, Charlottesville.

Correspondence to Richard J. Price, PhD, Associate Professor, Department of Biomedical Engineering, University of Virginia, Box 800759, UVA Health System, Charlottesville, VA 22908. E-mail rprice{at}virginia.edu

Objective— Bone marrow-derived cells (BMCs) and inflammatory chemokine receptors regulate arteriogenesis and angiogenesis. Here, we tested whether arteriolar remodeling in response to an inflammatory stimulus is dependent on BMC-specific chemokine (C-C motif) receptor 2 (CCR2) expression and whether this response involves BMC transdifferentiation into smooth muscle.

Methods and Results— Dorsal skinfold window chambers were implanted into C57Bl/6 wild-type (WT) mice, as well as the following bone marrow chimeras (donor-host): WT-WT, CCR2–/–-WT, WT-CCR2–/–, and EGFP+-WT. One day after implantation, tissue MCP-1 levels rose from "undetectable" to 463pg/mg, and the number of EGFP+ cells increased more than 4-fold, indicating marked inflammation. A 66% (28 µm) increase in maximum arteriolar diameter was observed over 7 days in WT-WT mice. This arteriolar remodeling response was completely abolished in CCR2–/–-WT mice but largely rescued in WT-CCR2–/– mice. EGFP+ BMCs were numerous throughout the tissue, but we found no evidence that EGFP+ BMCs transdifferentiate into smooth muscle, based on examination of >800 arterioles and venules.

Conclusions— BMC-specific CCR2 expression is required for injury/inflammation-associated arteriolar remodeling, but this response is not characterized by the differentiation of BMCs into smooth muscle.

Dorsal skinfold window chamber implantation elicits inflammation, arteriolar remodeling, and bone marrow–derived cell recruitment without transdifferentiation into smooth muscle. In this model, both arteriolar remodeling and monocyte/macrophage recruitment are dependent on bone marrow–derived cell-specific CCR2 expression.


Key Words: microcirculation • arteriolar remodeling • CCR2 • MCP-1 • bone marrow derived cells